Haemonetics (HAE) Shares Outstanding (2010 - 2026)

Haemonetics has reported Shares Outstanding for 17 years, with the latest figure at $45.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 6.15% year-over-year to $45.3 million; the trailing twelve-month figure through Mar 2026 stood at $45.3 million (down 6.15% YoY), and the FY2026 full-year result was $45.3 million, down 6.15% from the prior year.
• Shares Outstanding for Q1 2026 stood at $45.3 million, down from $46.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $51.3 million in Q3 2022, with the low at $45.3 million in Q1 2026.
• Average Shares Outstanding over 5 years is $49.7 million, with a median of $50.5 million recorded in 2022.
• Year-over-year, Shares Outstanding increased 0.88% in 2024 and dropped 7.21% in 2025.
• Tracing HAE's Shares Outstanding over 5 years: stood at $50.4 million in 2022, then climbed by 0.68% to $50.8 million in 2023, then fell by 1.08% to $50.2 million in 2024, then fell by 6.78% to $46.8 million in 2025, then fell by 3.37% to $45.3 million in 2026.
• The last three Shares Outstanding figures came in at $45.3 million (Q1 2026), $46.8 million (Q4 2025), and $46.7 million (Q3 2025), per Business Quant data.

Peer Comparison